TARGETING VON WILLEBRAND FACTOR TO MODEL DISEASE IN HUMAN PLURIPOTENT STEM CELLS

    公开(公告)号:US20240376437A1

    公开(公告)日:2024-11-14

    申请号:US18444289

    申请日:2024-02-16

    Abstract: The present disclosure provides methods and compositions useful for generating cellular models of VWF disease from human pluripotent stem cells. In one aspect, the present disclosure relates to a method for the generation of an in vitro cellular model of VWF disease comprising VWF disease-relevant endothelial cells derived from human pluripotent stem cells (hPSCs). In an embodiment, the human pluripotent stem cells (hPSCs) are treated with an agent effective in suppressing or deleting at least one gene sequence encoding a protein and/or a subunit thereof, where the protein and/or subunit thereof is associated with VWF-linked secretion. The present disclosure also provides uses of the cellular models disclosed herein.

    DIFFERENTIATION OF HUMAN TISSUES WITHOUT CILIA FROM PLURIPOTENT STEM CELLS

    公开(公告)号:US20250027932A1

    公开(公告)日:2025-01-23

    申请号:US18713882

    申请日:2022-11-30

    Abstract: Embodiments of the present disclosure provide compositions and methods for making a genetically modified pluripotent stem cell, wherein the genetically modified pluripotent stem cell lacks cilia. Embodiments of the present disclosure also provide compositions and methods for using the genetically modified pluripotent stem cell to generate genetically modified organoids, wherein the genetically modified organoids lack cilia. Knockout
    Isogenic Gene
    guide RNA
    Mutants
    Controls KIF3A
    CATATGGACAAACCGGAAC
    7
    7 KIF3B
    TTCGCTGTCGGCCCATGAA
    3
    3 TACACCATGGAAGGAATCCG
    4
    2

Patent Agency Ranking